Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl versus methadone for opioid withdrawal syndrome in toxicology ICU patients
IRCT20150110020624N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of fentanyl and methadone in opioid withdrawal (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Response to treatment, Time needed to respond to therapy and 1 more. Started Aug 2020; status: completed.
02
Drugs
fentanylmethadone
03
Conditions
opioid withdrawal
Beyond the preview
Go deeper on IRCT20150110020624N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150110020624N2.